ADCC	Antibody-dependent cell-mediated cytotoxicity
AML	Acute myeloid leukemia
APC	Antigen-presenting cell
BCRs	B-cell receptors
CAR	Chimeric antigen receptor
CAR-Ts	Chimeric antigen receptor T cells
CDC	Complement-dependent cytotoxicity
CTLA-4	Cytotoxic T-lymphocyte-associated protein 4
CTLs	Cytotoxic T cells
DAMPs	Damage-associated molecular patterns
DCs	Dendritic cells
ECM	Extracellular matrix
EGF	Epidermal growth factor
FAK	Focal adhesion kinase
FDA	Food and Drug Administration
GBM	Glioblastoma multiforme
ICIs	Immune checkpoint inhibitors
IFN-γ	Interferon-γ
IL	Interleukin
LNPs	Lipid nanoparticles
LOX	Lysyl oxidase
M1	Classically activated macrophages
M2	Alternatively activated macrophages
MAC	Membrane attack complex
mCRPC	Metastatic castration-resistant prostate cancer
M-CSF	Macrophage colony-stimulating factor
MDSCs	Myeloid-derived suppressor cells
MHC	Major histocompatibility complex
MM	Multiple myeloma
MMPs	Matrix metalloproteinases
NGS	Next-generation sequencing
NK	Natural killer cells
NSCLC	Non-small-cell lung cancer
PAMPs	Pathogen-associated molecular patterns
PBMCs	Peripheral blood mononuclear cells
PD-1	Programmed cell death protein 1
PD-L1	Programmed cell death ligand 1
TAAs	Tumor-associated antigens
TAMs	Tumor-associated macrophages
TCR	T-cell receptor
TGF-β	Transforming growth factor-β
Th	Helper T cells
TLR	Toll-like receptor
TME	Tumor microenvironment
TNF-α	Tumor necrosis factor-α
Tregs	Regulatory T cells
TSAs	Tumor-specific antigens
VEGF	Vascular endothelial growth factor